SITC compared with TBPH: revenue, margins and what each company keeps, and the suppliers and customers both name

SITCSITE Centers Corp.

Mkt capRevenueRevenue

TBPHTheravance Biopharma, Inc.

Mkt capRevenueRevenue

Compare

SITCSITE Centers Corp.

TBPHTheravance Biopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SITC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 3 '26±33.0%0.00%×0.00

Aug 4 '26±18.2%▼−4.23%×0.23

May 8 '26±25.4%▼−0.89%×0.04

Feb 27 '26±42.1%▼−8.74%×0.21

TBPH

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 10 '26±6.0%▼−0.12%×0.02

May 7 '26±10.3%▲+0.47%×0.05

= impliedSITC realized, solidTBPH realized, hatchedOne scale, both sides: full bar = 43%× = |realized| ÷ impliedSource: market data

Mar 19 '26

±12.0%

▲+1.30%

×0.11

Nov 11 '25±24.6%▲+22.68%×0.92

SITCSITE Centers Corp.

0.67▲+17.18%· post 0.67

Mkt cap$35.1MRevenue$12MQ3 FY26Revenue$501MFY25

TBPHTheravance Biopharma, Inc.

17.03▲+0.02%· post 17.04

ClosedNov 6 '26

Mkt cap$884.2MRevenue$21MQ2 FY26Revenue$107MFY25

Compare

ClosedNov 6 '26

SITCSITE Centers Corp.

TBPHTheravance Biopharma, Inc.

0.67▲+17.18%post 0.67

Price

17.03▲+0.02%post 17.04

$35.1M

Mkt cap

$884.2M

Q3 FY26$12M

Revenue

$21MQ2 FY26

FY25$501M

Revenue

$107MFY25

SITC0.67▲+17.18%vsTBPH17.03▲+0.02%ClosedNov 6 '26